SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
48.65    0.95 (1.99%)
Bid:
47.80
Ask:
49.65
Spread: 1.85 (3.87%)
Market Cap: £193.68m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Acquisition

17 Feb 2022 07:00

RNS Number : 9338B
CLS Holdings PLC
17 February 2022
 

 

Release date: 17 February 2022

Embargoed until: 07:00 am

 

 

CLS Holdings plc ("CLS" or the "Group")

announces the €25 million acquisition of an office building in Dusseldorf

 

CLS announces that is has unconditionally exchanged contracts to acquire a 9,168 sqm / 98,684 sq. ft office building in Dusseldorf for €25 million (€2,724 per sqm) excluding costs from alstria office REIT-AG.

 

Kanzlerstraße 8 is situated in a well-connected and growing submarket in Dusseldorf. The overground station, Dusseldorf Rath, and the underground station, Rather Waldstadion, are both within 400m of the asset. The airport can be reached within 10 minutes by car and the central station in 16 minutes by overground. Dusseldorf is one of the main political, economic, and cultural centre of the Rhine-Ruhr region with a population of c. 11 million and one of the "Top 7" office markets.

 

The property is currently occupied by three tenants including the anchor tenant Amevida (c. 70% by space), Kinderparadies, and ConSol with a WAULT of c. 8 years. CLS plans to let remaining vacant space, enhance the carpark and ESG credentials, and manage the future lease breaks. The property currently has a net initial yield of 5.1% and a reversionary yield of 5.7%.

 

The acquisition is expected to complete in April 2022.

 

Fredrik Widlund, Chief Executive Officer of CLS, commented:

 

"This asset is a well-located office building and benefits from an existing strong tenant base with the opportunity to secure market rents and valuation uplifts in the years ahead. This acquisition also reflects our confidence in the underlying strength of the German office market, particularly in key regional cities. We look forward to working with the tenants to improve the building further and enhancing its sustainability."

 

-ends-

For further information, please contact:

 

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

Fredrik Widlund, Chief Executive Officer

Andrew Kirkman, Chief Financial Officer

+44 (0)20 7582 7766

 

Liberum Capital

Richard Crawley

Jamie Richards

+44 (0)20 3100 2222

 

Panmure Gordon

Hugh Rich

+44 (0)20 7886 2733

 

Berenberg

Matthew Armitt

Richard Bootle

+44 (0)20 3207 7800

 

Edelman Smithfield (Financial PR)Alex Simmons

Rob Yates

+44 (0)20 3047 2000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQFZGMZZVZGZZZ
Date   Source Headline
6th May 20206:15 pmRNSDirector/PDMR Shareholding
1st May 202012:13 pmRNSDirector/PDMR Shareholding
29th Apr 202011:21 amRNSDisclosure of rights attached to equity shares
23rd Apr 20205:16 pmRNSResult of AGM
23rd Apr 202012:14 pmRNSResult of AGM
23rd Apr 202012:12 pmRNSAppointment of Senior Independent Director
14th Apr 20203:24 pmRNSDirector/PDMR Shareholding
9th Apr 20204:35 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSTrading Statement
6th Apr 20205:36 pmRNSDirector/PDMR Shareholding
1st Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20206:06 pmRNSDirector/PDMR Shareholding
24th Mar 20201:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20204:42 pmRNSAnnual Financial Report
23rd Mar 20203:09 pmRNSDirector/PDMR Shareholding
20th Mar 20205:14 pmRNSDirector/PDMR Shareholding
20th Mar 202010:15 amRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 20208:24 amRNSDirector/PDMR Shareholding
12th Mar 20205:22 pmRNSDirector/PDMR Shareholding
10th Mar 20208:53 amRNSDirector/PDMR Shareholding
6th Mar 20205:31 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results
24th Feb 20207:00 amRNSNotice of Results
17th Feb 202010:26 amRNSHolding(s) in Company
12th Feb 20202:14 pmRNSDirector/PDMR Shareholding
4th Feb 20206:14 pmRNSNotification of change in a Director's details
23rd Jan 20205:13 pmRNSDirector/PDMR Shareholding
14th Jan 20204:47 pmRNSDirector/PDMR Shareholding
8th Jan 20207:00 amRNSAcquisition
31st Dec 20197:00 amRNSSale of the UK regional office portfolio
11th Dec 20195:16 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSTrading Statement
20th Nov 20197:00 amRNSAppointment of independent Non-Executive Director
13th Nov 20197:00 amRNSAcquisition
8th Nov 20194:07 pmRNSDirector/PDMR Shareholding
17th Oct 20194:53 pmRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSAcquisition
11th Oct 20195:03 pmRNSDirector/PDMR Shareholding
3rd Oct 20197:00 amRNSAcquisition
6th Sep 20195:41 pmRNSDirector/PDMR Shareholding
3rd Sep 20197:00 amRNSShareholding in Catena AB
2nd Sep 20194:31 pmRNSShareholding in Catena AB
14th Aug 20194:05 pmRNSDirector/PDMR Shareholding
14th Aug 20197:00 amRNSHalf-year Report
8th Aug 20199:09 amRNSDirector/PDMR Shareholding
5th Aug 20195:06 pmRNSNotice of Half Year Results
22nd Jul 20198:03 amRNSCLS announces sales in Munich and Dusseldorf
17th Jul 201911:29 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.